| LINE ITEM (USD / %) | FY 2025
FILED 2026-01-31 | FY 2024
FILED 2025-02-01 | FY 2023
FILED 2024-02-03 |
|---|---|---|---|
| Revenue (Total Sales) | $2.65B | $2.27B | $2.10B |
| YoY Revenue Growth % | +16.6% | +8.0% | — |
| Gross Profit | $1.07B | $914.5M | — |
| Gross Margin % | 40.5% | 40.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $297.7M | $249.5M | $227.8M |
| Operating Margin % | 11.2% | 11.0% | 10.8% |
| Net Income (GAAP) | $240.6M | $199.8M | $181.4M |
| EBITDA (Normalized) | $379.2M | $345.9M | $303.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $296.5M | $227.5M | $254.5M |
| Capital Expenditures (CapEx) | $101.9M | $120.6M | $94.6M |
| Free Cash Flow (FCF) | $194.7M | $106.9M | $159.9M |
| FCF Margin % | 7.3% | 4.7% | 7.6% |
| Return on Invested Capital (ROIC %) | 11.2% | 10.5% | 9.9% |
| Cash & Short-Term Equivalents | $259.7M | $205.1M | — |
| Total Debt (Short + Long Term) | $480.1M | $389.6M | $706.6M |
| Total Stockholders' Equity | $1.89B | $1.70B | $1.45B |